<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02175134</url>
  </required_header>
  <id_info>
    <org_study_id>2014-0616</org_study_id>
    <nct_id>NCT02175134</nct_id>
  </id_info>
  <brief_title>IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis</brief_title>
  <official_title>IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The diagnosis of tuberculous peritonitis (TBP) is still challenging, and largely dependent on
      invasive procedures such as laparoscopy. A recently developed RD-1 gene-based assay for
      diagnosing TBP shows has given promising results. The investigators thus created a 2-step
      algorithm using the Blood/Ascites ELISPOT assays and adenosine deaminase (ADA) in ascites for
      differentiation of TBP from other diagnoses (Blood ELISPOT ≥6 spots or ADA ≥ 21 U/L' as a
      rule-out test and 'Ascites/Blood ratio ≥3' as a rule-in test). This study is the randomized
      controlled trial on whether this 2-step algorithm-based approach can reduce the laparoscopic
      biopsy for the diagnosis of TBP in patients with suspected TBP.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the frequency of laparoscopic biopsy</measure>
    <time_frame>1 week after the enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the frequency of correct or wrong diagnosis</measure>
    <time_frame>6 months after the enrollment</time_frame>
    <description>the frequency of correct or wrong diagnosis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Suspected Tuberculous Peritonitis</condition>
  <arm_group>
    <arm_group_label>conventional diagnostic flow arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Perform the laparoscopic biopsy as a discretion of attending physician's decision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>two-step algorithm-based approach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Perform the laparoscopic biopsy as a discretion of attending physician's decision, but if the below conditions are met, do not perform the laparoscopic biopsy.
Blood ELISPOT &gt;= 6 spots or ascites adenosine deaminase &gt; 20 IU/L, and
Ascites ELISPOT/Blood ELISPOT rato &gt; 3</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood and Ascites ELISPOT</intervention_name>
    <arm_group_label>two-step algorithm-based approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients with suspected tuberculous peritonitis

          -  age 16 or more

          -  formal informed consent

        Exclusion Criteria:

          -  not specified
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sung-Han Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sung-Han Kim, MD</last_name>
    <phone>82-2-3010-3305</phone>
    <email>kimsunghanmd@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung-Han Kim, MD</last_name>
      <phone>82-2-3010-3305</phone>
      <email>kimsunghanmd@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2014</study_first_submitted>
  <study_first_submitted_qc>June 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <last_update_submitted>July 4, 2014</last_update_submitted>
  <last_update_submitted_qc>July 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Sung-Han Kim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>tuberculosis</keyword>
  <keyword>peritonitis</keyword>
  <keyword>laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peritonitis</mesh_term>
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Peritonitis, Tuberculous</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferon-gamma</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

